SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms

Volume: 27, Issue: 3, Pages: 935 - 949
Published: Feb 3, 2021
Abstract
This paper highlights the cardioprotective potential of sodium-glucose cotransporter 2 inhibitors (SLGT2i), as well as several most discussed mechanisms responsible for their cardioprotection. Cardiovascular diseases are considered a primary cause of death in nearly 80% of type 2 diabetes mellitus (T2DM) patients, with a 2-4-fold greater incidence of heart failure (HF) among diabetics. As novel hypoglycemics, SGLT2i showed exceptional...
Paper Details
Title
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms
Published Date
Feb 3, 2021
Volume
27
Issue
3
Pages
935 - 949
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.